Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid

Saved in:
Bibliographic Details
Published in:Medical hypotheses 2020-10, Vol.143, p.109891-109891, Article 109891
Main Authors: Unal, Gokhan, Turan, Bahadir, Balcioglu, Yasin Hasan
Format: Article
Language:English
Subjects:
Antimanic Agents
Betacoronavirus
Coronavirus
Coronavirus Infections
COVID-19
Cytokines
Humans
Immunomodulation
Immunopharmacology
Letter to Editors
Lithium
Mood stabilizers
Pandemics
Pneumonia, Viral
SARS-CoV-2
Valproic Acid
Viral replication
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c455t-1f4bdb471116271529f3accd43f40b49003bf012e9b55f1319eed6123ac2c7293
cites cdi_FETCH-LOGICAL-c455t-1f4bdb471116271529f3accd43f40b49003bf012e9b55f1319eed6123ac2c7293
container_end_page 109891
container_issue
container_start_page 109891
container_title Medical hypotheses
container_volume 143
creator Unal, Gokhan
Turan, Bahadir
Balcioglu, Yasin Hasan
description
doi_str_mv 10.1016/j.mehy.2020.109891
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7255327</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0306987720312573</els_id><sourcerecordid>2410361547</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-1f4bdb471116271529f3accd43f40b49003bf012e9b55f1319eed6123ac2c7293</originalsourceid><addsrcrecordid>eNp9kU-LFDEQxYMo7rj6BTxIH730bCpJdyYiwjL-2YGF9aCCp5BOV89k6HTapHtgv71pZl304qng1a9eFfUIeQ10DRTqq-Pa4-F-zShbBLVR8ISsoOKsZFLKp2RFOa1LtZHygrxI6UgpVYJvnpMLzoTaUCpX5OfO-3kI48FEb2zow95Z0xfeDGaPHoepCF2xvfux-1iCeld8DVPWXCamA0Yz4jw5W8TQ48KdTD_GkAVjXfuSPOtMn_DVQ70k3z9_-ra9KW_vvuy217elFVU1ldCJpm2EBICaSaiY6rixthW8E7QRilLedBQYqqaqOuCgENsaWIaYlUzxS_Lh7DvOjcfW5vui6fUYnTfxXgfj9L-dwR30Ppy0ZFX-lcwGbx8MYvg1Y5q0d8li35sBw5w0E0B5DZVYUHZGbQwpRewe1wDVSyb6qJdM9JKJPmeSh978feDjyJ8QMvD-DGB-08lh1Mk6HCy2LqKddBvc__x_A5VfnjI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2410361547</pqid></control><display><type>article</type><title>Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid</title><source>ScienceDirect Freedom Collection</source><creator>Unal, Gokhan ; Turan, Bahadir ; Balcioglu, Yasin Hasan</creator><creatorcontrib>Unal, Gokhan ; Turan, Bahadir ; Balcioglu, Yasin Hasan</creatorcontrib><identifier>ISSN: 0306-9877</identifier><identifier>EISSN: 1532-2777</identifier><identifier>DOI: 10.1016/j.mehy.2020.109891</identifier><identifier>PMID: 32498007</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Antimanic Agents ; Betacoronavirus ; Coronavirus ; Coronavirus Infections ; COVID-19 ; Cytokines ; Humans ; Immunomodulation ; Immunopharmacology ; Letter to Editors ; Lithium ; Mood stabilizers ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2 ; Valproic Acid ; Viral replication</subject><ispartof>Medical hypotheses, 2020-10, Vol.143, p.109891-109891, Article 109891</ispartof><rights>2020 Elsevier Ltd</rights><rights>2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-1f4bdb471116271529f3accd43f40b49003bf012e9b55f1319eed6123ac2c7293</citedby><cites>FETCH-LOGICAL-c455t-1f4bdb471116271529f3accd43f40b49003bf012e9b55f1319eed6123ac2c7293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32498007$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Unal, Gokhan</creatorcontrib><creatorcontrib>Turan, Bahadir</creatorcontrib><creatorcontrib>Balcioglu, Yasin Hasan</creatorcontrib><title>Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid</title><title>Medical hypotheses</title><addtitle>Med Hypotheses</addtitle><subject>Antimanic Agents</subject><subject>Betacoronavirus</subject><subject>Coronavirus</subject><subject>Coronavirus Infections</subject><subject>COVID-19</subject><subject>Cytokines</subject><subject>Humans</subject><subject>Immunomodulation</subject><subject>Immunopharmacology</subject><subject>Letter to Editors</subject><subject>Lithium</subject><subject>Mood stabilizers</subject><subject>Pandemics</subject><subject>Pneumonia, Viral</subject><subject>SARS-CoV-2</subject><subject>Valproic Acid</subject><subject>Viral replication</subject><issn>0306-9877</issn><issn>1532-2777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kU-LFDEQxYMo7rj6BTxIH730bCpJdyYiwjL-2YGF9aCCp5BOV89k6HTapHtgv71pZl304qng1a9eFfUIeQ10DRTqq-Pa4-F-zShbBLVR8ISsoOKsZFLKp2RFOa1LtZHygrxI6UgpVYJvnpMLzoTaUCpX5OfO-3kI48FEb2zow95Z0xfeDGaPHoepCF2xvfux-1iCeld8DVPWXCamA0Yz4jw5W8TQ48KdTD_GkAVjXfuSPOtMn_DVQ70k3z9_-ra9KW_vvuy217elFVU1ldCJpm2EBICaSaiY6rixthW8E7QRilLedBQYqqaqOuCgENsaWIaYlUzxS_Lh7DvOjcfW5vui6fUYnTfxXgfj9L-dwR30Ppy0ZFX-lcwGbx8MYvg1Y5q0d8li35sBw5w0E0B5DZVYUHZGbQwpRewe1wDVSyb6qJdM9JKJPmeSh978feDjyJ8QMvD-DGB-08lh1Mk6HCy2LqKddBvc__x_A5VfnjI</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Unal, Gokhan</creator><creator>Turan, Bahadir</creator><creator>Balcioglu, Yasin Hasan</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201001</creationdate><title>Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid</title><author>Unal, Gokhan ; Turan, Bahadir ; Balcioglu, Yasin Hasan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-1f4bdb471116271529f3accd43f40b49003bf012e9b55f1319eed6123ac2c7293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antimanic Agents</topic><topic>Betacoronavirus</topic><topic>Coronavirus</topic><topic>Coronavirus Infections</topic><topic>COVID-19</topic><topic>Cytokines</topic><topic>Humans</topic><topic>Immunomodulation</topic><topic>Immunopharmacology</topic><topic>Letter to Editors</topic><topic>Lithium</topic><topic>Mood stabilizers</topic><topic>Pandemics</topic><topic>Pneumonia, Viral</topic><topic>SARS-CoV-2</topic><topic>Valproic Acid</topic><topic>Viral replication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Unal, Gokhan</creatorcontrib><creatorcontrib>Turan, Bahadir</creatorcontrib><creatorcontrib>Balcioglu, Yasin Hasan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medical hypotheses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Unal, Gokhan</au><au>Turan, Bahadir</au><au>Balcioglu, Yasin Hasan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid</atitle><jtitle>Medical hypotheses</jtitle><addtitle>Med Hypotheses</addtitle><date>2020-10-01</date><risdate>2020</risdate><volume>143</volume><spage>109891</spage><epage>109891</epage><pages>109891-109891</pages><artnum>109891</artnum><issn>0306-9877</issn><eissn>1532-2777</eissn><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>32498007</pmid><doi>10.1016/j.mehy.2020.109891</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0306-9877
ispartof Medical hypotheses, 2020-10, Vol.143, p.109891-109891, Article 109891
issn 0306-9877
1532-2777
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7255327
source ScienceDirect Freedom Collection
subjects Antimanic Agents
Betacoronavirus
Coronavirus
Coronavirus Infections
COVID-19
Cytokines
Humans
Immunomodulation
Immunopharmacology
Letter to Editors
Lithium
Mood stabilizers
Pandemics
Pneumonia, Viral
SARS-CoV-2
Valproic Acid
Viral replication
title Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A41%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunopharmacological%20management%20of%20COVID-19:%20Potential%20therapeutic%20role%20of%20valproic%20acid&rft.jtitle=Medical%20hypotheses&rft.au=Unal,%20Gokhan&rft.date=2020-10-01&rft.volume=143&rft.spage=109891&rft.epage=109891&rft.pages=109891-109891&rft.artnum=109891&rft.issn=0306-9877&rft.eissn=1532-2777&rft_id=info:doi/10.1016/j.mehy.2020.109891&rft_dat=%3Cproquest_pubme%3E2410361547%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-1f4bdb471116271529f3accd43f40b49003bf012e9b55f1319eed6123ac2c7293%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2410361547&rft_id=info:pmid/32498007&rfr_iscdi=true